Acidic domain is indispensable for MDM2 to negatively regulate the acetylation of p53

被引：8

作者：

Wang, Qian ^{[1
]}

Yang, Ying ^{[1
]}

Wang, Lan ^{[1
]}

Zhang, Ping-zhao ^{[1
]}

Yu, Long ^{[1
]}

机构：

[1] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2008年 / 374卷 / 03期

关键词：

p53; acetylation; MDM2; acidic domain; p300; HDAC1;

D O I：

10.1016/j.bbrc.2008.07.038

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

MDM2 is the most important negative regulator of tumor suppressor p53. Both RING finger domain and acidic domain of MDM2 contribute to the ubiquitination of p53. The crosstalk between ubiquitination and acetylation of p53 prompts us to examine whether acidic domain is essential for MDM2 to regulate the acetylation of p53. We find that the acidic domain of MDM2 is necessary to inhibit p300-mediated acetylation of p53 as well as to mediate the deacetylation of p53. Our results indicate that acidic domain of MDM2 Provides essential information for acetyltransferase p300 and deacetylase HDAC1 and is indispensable for MDM2 to negatively regulate the acetylation of p53. (C) 2008 Elsevier Inc. All rights reserved.

引用

页码：437 / 441

页数：5

共 25 条

[1] Post-translational modification of p53 in tumorigenesis [J].

Bode, AM ;

Dong, ZG .

NATURE REVIEWS CANCER, 2004, 4 (10) :793-805

[2] Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation [J].

Brooks, CL ;

Gu, W .

CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (02) :164-171

[3] Inhibiting the p53-MDM2 interaction:: An important target for cancer therapy [J].

Chène, P .

NATURE REVIEWS CANCER, 2003, 3 (02) :102-109

[4] Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53 [J].

Fang, SY ;

Jensen, JP ;

Ludwig, RL ;

Vousden, KH ;

Weissman, AM .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :8945-8951

[5] p300/MDM2 complexes participate in MDM2-mediated p53 degradation [J].

Grossman, SR ;

Perez, M ;

Kung, AL ;

Joseph, M ;

Mansur, C ;

Xiao, ZX ;

Kumar, S ;

Howley, PM ;

Livingston, DM .

MOLECULAR CELL, 1998, 2 (04) :405-415

[6] Activity of MDM2, a ubiquitin Ligase, toward p53 or itself is dependent on the RING finger domain of the ligase [J].

Honda, R ;

Yasuda, H .

ONCOGENE, 2000, 19 (11) :1473-1476

[7] p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2 [J].

Ito, A ;

Lai, CH ;

Zhao, X ;

Saito, S ;

Hamilton, MH ;

Appella, E ;

Yao, TP .

EMBO JOURNAL, 2001, 20 (06) :1331-1340

[8] MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation [J].

Ito, A ;

Kawaguchi, Y ;

Lai, CH ;

Kovacs, JJ ;

Higashimoto, Y ;

Appella, E ;

Yao, TP .

EMBO JOURNAL, 2002, 21 (22) :6236-6245

[9] Mutation at p53 serine 389 does not rescue the embryonic lethality in mdm2 or mdm4 null mice [J].

Iwakuma, T ;

Parant, JM ;

Fasulo, M ;

Zwart, E ;

Jacks, T ;

de Vries, A ;

Lozano, G .

ONCOGENE, 2004, 23 (46) :7644-7650

[10] MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation [J].

Jin, YT ;

Zeng, SX ;

Dai, MS ;

Yang, XJ ;

Lu, H .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (34) :30838-30843

← 1 2 3 →